Zacks Investment Research on MSN
Pacific Biosciences of California (PACB) stock sinks as market gains: Here's why
In the latest close session, Pacific Biosciences of California (PACB) was down 2.89% at $1.68. The stock fell short of the S&P 500, which registered a gain of 0.79% for the day. Meanwhile, the Dow ...
Pacific Biosciences of California is back in focus as analysts adjust their price targets by increments of $0.50, reflecting ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss of $0.12 per share was 14.2% above analysts’ ...
PacBio and Intus Bio have launched GutID, the first commercial human gut health test, showcasing their collaboration and innovation in microbiome research. GutID utilizes PacBio's HiFi sequencing ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
View Pacific Biosciences of California, Inc. PACB stock quote prices, financial information, real-time forecasts, and company news from CNN.
Pacific Biosciences of California (PACB) shares fell 16% after the company reported Q1 results that included a wider-than-expected revenue miss and weaker profitability metrics. PacBio reported Q1 non ...
Pacific Biosciences of California, Inc. (PACB Quick Quote PACB - Free Report) , popularly known as PacBio, has been gaining from its continued focus on research and development. The optimism, led by ...
Appointment of David Ruggiero as Global Head of Sales & Service highlights the company's commitment to strengthening its leadership team with experienced professionals. Mr. Ruggiero brings over two ...
Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue of $18.9 million as demand for long-read sequencing ...
PacBio and DNAstack launched a global federated HiFi genome dataset spanning 15 countries. The consortium links 10,000 genomes, enabling secure cross-border rare disease research. PACB taps a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results